Cargando…
Moral motivation regarding dementia risk testing among affected persons in Germany and Israel
Recent advances in biomarkers may soon make it possible to identify persons at high risk for late-onset Alzheimer’s disease at a presymptomatic (preclinical) stage. Popular demand for testing is increasing despite the lack of cure and effective prevention options and despite uncertainties regarding...
Autores principales: | Alpinar-Sencan, Zümrüt, Schicktanz, Silke, Ulitsa, Natalie, Shefet, Daphna, Werner, Perla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626915/ https://www.ncbi.nlm.nih.gov/pubmed/34290115 http://dx.doi.org/10.1136/medethics-2020-106990 |
Ejemplares similares
-
Addressing ethical challenges of disclosure in dementia prediction: limitations of current guidelines and suggestions to proceed
por: Alpinar-Sencan, Zümrüt, et al.
Publicado: (2020) -
Diversity and uniformity in genetic responsibility: moral attitudes of patients, relatives and lay people in Germany and Israel
por: Raz, Aviad E., et al.
Publicado: (2009) -
Exploring the Motivations for Completing Advance Care Directives: A Qualitative Study of Majority/Minority Israeli People Without Dementia
por: Werner, Perla, et al.
Publicado: (2022) -
Patient Representation and Advocacy for Alzheimer Disease in Germany and Israel
por: Schicktanz, Silke, et al.
Publicado: (2018) -
Beyond cultural stereotyping: views on end-of-life decision making among religious and secular persons in the USA, Germany, and Israel
por: Schweda, Mark, et al.
Publicado: (2017)